FIELD: medicine.
SUBSTANCE: what is presented is using zincatrane (Citrimin) as an agent stimulating expression of matrix RNA of tryptophanyl-tRNA-synthetase.
EFFECT: more effective use.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF PROTATRANE 4-CHLORO-2-METHYLPHENOXIACETATE (CHLORCREZACINE) FOR TRYPTOPHANYL-tRNA-SYNTHETASE MATRIX RNA EXPRESSION STIMULATION | 2016 |
|
RU2623035C1 |
HERMATRANOL HYDRATE STIMULATING TRYPTOPHANYL-TRNA-SYNTHETASE MATRIX RNA EXPRESSION | 2014 |
|
RU2553986C1 |
AGENT STIMULATING EXPRESSION OF MATRIX RNA OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2010 |
|
RU2429836C1 |
METHOD OF ASSESSMENT OF GENE EXPRESSION OF TRYPTOPHANYL - TOTAL RNA SYNTHETASE AS MARKER OF OVERWORK DURING TRAINING OF ATHLETES - STATE OF OVERTRAINING | 2013 |
|
RU2521655C1 |
USING COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE AND ZINC BIS-(2-METHYLPHENOXYACETATE) (CINKATRAN) AS AGENT SUPPRESSING TOTAL ACTIVITY OF BASIC (ALKALINE) MONONUCLEAR PHOSPHOLIPASE A2 | 2014 |
|
RU2546537C1 |
SUBSTANCE STIMULATING GENE EXPRESSION OF COACTIVATOR PGC-1α | 2014 |
|
RU2559779C1 |
COMPLEX OF TRIS-(2-HYDROXYETHYL)AMINE WITH ZINK BIS-(2-METHYLPHENOXYACETATE), INCREASING CYTOKIN ACTIVITY OF TOTAL TRIPTOPHANYL-tRNA-SYNTHETASE | 2011 |
|
RU2457837C1 |
AGENT FOR TOTAL TRYPTOPHANYL-tRNS-SYNTHETASE ACTIVATION | 2009 |
|
RU2407526C1 |
METHOD FOR CORRECTING ATHEROGENESIS EXPERIMENTALLY USING 1-HYDROXYGERMATRANE | 2020 |
|
RU2741229C1 |
1-HYDROXYGERMATRANE USAGE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT | 2020 |
|
RU2742972C1 |
Authors
Dates
2015-02-10—Published
2014-03-27—Filed